Trial intelligence / Profile preview

Comparative study of Structum and Chondrosulf in symptomatic knee osteoarthritis

2008-000871-19Phase 4Completed

Sponsor
Pierre Fabre Laboratories
Start
Mar 2008
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of chondroitin sulfate in osteoarthritis (OA) and knee osteoarthritis (OA) (2 arms), sponsored by Pierre Fabre Laboratories. Primary endpoints: Global pain score change and Lequesne Index change. Started Mar 2008; status: completed.

02

Drugs

chondroitin sulfate
03

Conditions

osteoarthritis (OA)knee osteoarthritis (OA)

Beyond the preview

Go deeper on 2008-000871-19.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2008-000871-19.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call